Effects of low-dose doxycycline on cytokine secretion in human monocytes stimulated with Aggregatibacter actinomycetemcomitans.

[1]  C. Ulm,et al.  Serum cytokine levels in periodontitis patients in relation to the bacterial load. , 2011, Journal of periodontology.

[2]  G. Emingil,et al.  Subantimicrobial-dose doxycycline and cytokine-chemokine levels in gingival crevicular fluid. , 2011, Journal of periodontology.

[3]  S. Moskalewski,et al.  Influence of LPS, TNF, TGF-ß1 and IL-4 on the expression of MMPs, TIMPs and selected cytokines in rat synovial membranes incubated in vitro. , 2010, International journal of molecular medicine.

[4]  R. Gonçalves,et al.  Levels of Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, inflammatory cytokines and species-specific immunoglobulin G in generalized aggressive and chronic periodontitis. , 2010, Journal of periodontal research.

[5]  D. Haubek.  The highly leukotoxic JP2 clone of Aggregatibacter actinomycetemcomitans: evolutionary aspects, epidemiology and etiological role in aggressive periodontitis , 2010, APMIS. Supplementum.

[6]  S. Socransky,et al.  Relationships among gingival crevicular fluid biomarkers, clinical parameters of periodontal disease, and the subgingival microbiota. , 2010, Journal of periodontology.

[7]  J. J. Taylor,et al.  Differential expression of immunoregulatory genes in monocytes in response to Porphyromonas gingivalis and Escherichia coli lipopolysaccharide , 2009, Clinical and experimental immunology.

[8]  T. Kawai,et al.  Diminished Treatment Response of Periodontally Diseased Patients Infected with the JP2 Clone of Aggregatibacter (Actinobacillus) actinomycetemcomitans , 2009, Journal of Clinical Microbiology.

[9]  N. Bostanci,et al.  Porphyromonas gingivalis culture supernatants differentially regulate interleukin-1beta and interleukin-18 in human monocytic cells. , 2009, Cytokine.

[10]  J. Oscarsson,et al.  Proinflammatory effect in whole blood by free soluble bacterial components released from planktonic and biofilm cells , 2008, BMC Microbiology.

[11]  D. Grenier,et al.  Doxycycline Reduces Lipopolysaccharide-Induced Inflammatory Mediator Secretion in Macrophage and Ex Vivo Human Whole Blood Models , 2008 .

[12]  A. Sjöstedt,et al.  IL-1beta secretion induced by Aggregatibacter (Actinobacillus) actinomycetemcomitans is mainly caused by the leukotoxin. , 2008, International journal of medical microbiology : IJMM.

[13]  G. Emingil,et al.  Post-treatment effects of subantimicrobial dose doxycycline on clinical parameters and gingival crevicular fluid transforming growth factor-beta1 in severe, generalized chronic periodontitis. , 2008, International journal of dental hygiene.

[14]  O. O. Yücel,et al.  Interleukin-11, interleukin-1beta, interleukin-12 and the pathogenesis of inflammatory periodontal diseases. , 2008, Journal of clinical periodontology.

[15]  E. Riley,et al.  IL-10: The Master Regulator of Immunity to Infection , 2008, The Journal of Immunology.

[16]  P. Lastres,et al.  Characterization of progressive periodontal lesions in chronic periodontitis patients: levels of chemokines, cytokines, matrix metalloproteinase-13, periodontal pathogens and inflammatory cells. , 2008, Journal of clinical periodontology.

[17]  N. Bostanci,et al.  Porphyromonas gingivalis antagonises Campylobacter rectus induced cytokine production by human monocytes. , 2007, Cytokine.

[18]  Georg Schett,et al.  Cytokines in the pathogenesis of rheumatoid arthritis , 2007, Nature Reviews Immunology.

[19]  S. Socransky,et al.  Clinical changes following four different periodontal therapies for the treatment of chronic periodontitis: 1-year results. , 2007, Journal of clinical periodontology.

[20]  U. Johansson,et al.  Interleukin-1alpha stimulation in monocytes by periodontal bacteria: antagonistic effects of Porphyromonas gingivalis. , 2007, Oral microbiology and immunology.

[21]  D. Fine,et al.  How we got attached to Actinobacillus actinomycetemcomitans: A model for infectious diseases. , 2006, Periodontology 2000.

[22]  S. Mansour,et al.  Sustained Interleukin‐6 and Interleukin‐8 Expression Following Infection with Chlamydia trachomatis Serovar L2 in a HeLa/THP‐1 Cell Co‐culture Model , 2006, Scandinavian journal of immunology.

[23]  P. Preshaw,et al.  Long-term treatment with sub-antimicrobial dose doxycycline has no antibacterial effect on intestinal flora. , 2005, Journal of clinical periodontology.

[24]  P. Marsh.  Dental plaque: biological significance of a biofilm and community life-style. , 2005, Journal of clinical periodontology.

[25]  Chi‐Cheng Tsai,et al.  Interleukin-12 and interleukin-16 in periodontal disease. , 2005, Cytokine.

[26]  P. Preshaw,et al.  Adjunctive subantimicrobial dose doxycycline in smokers and non-smokers with chronic periodontitis. , 2005, Journal of clinical periodontology.

[27]  G. Belibasakis,et al.  Cytokine responses of human gingival fibroblasts to Actinobacillus actinomycetemcomitans cytolethal distending toxin. , 2005, Cytokine.

[28]  G. Belibasakis,et al.  The Cytolethal Distending Toxin Induces Receptor Activator of NF-κB Ligand Expression in Human Gingival Fibroblasts and Periodontal Ligament Cells , 2005, Infection and Immunity.

[29]  J. Walters,et al.  Distribution of systemic ciprofloxacin and doxycycline to gingiva and gingival crevicular fluid. , 2004, Journal of periodontology.

[30]  Isao Ishikawa,et al.  Effect of low dose Actinobacillus actinomycetemcomitans lipopolysaccharide pretreatment on cytokine production by human whole blood. , 2004, Journal of periodontal research.

[31]  S. Ledbetter,et al.  The tetracycline analogs minocycline and doxycycline inhibit angiogenesis in vitro by a non-metalloproteinase-dependent mechanism , 2004, Cancer Chemotherapy and Pharmacology.

[32]  U. van der Velden,et al.  Increased release of IL-12p70 by monocytes after periodontal therapy. , 2003, Journal of clinical periodontology.

[33]  T. Krakauer,et al.  Doxycycline Is Anti-Inflammatory and Inhibits Staphylococcal Exotoxin-Induced Cytokines and Chemokines , 2003, Antimicrobial Agents and Chemotherapy.

[34]  D. Graves,et al.  The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction. , 2003, Journal of periodontology.

[35]  G. Trinchieri,et al.  Interleukin-12 and the regulation of innate resistance and adaptive immunity , 2003, Nature Reviews Immunology.

[36]  S. Akifusa,et al.  Recombinant Actinobacillus actinomycetemcomitansCytolethal Distending Toxin Proteins Are Required To Interact To Inhibit Human Cell Cycle Progression and To Stimulate Human Leukocyte Cytokine Synthesis , 2001, Infection and Immunity.

[37]  Michael T. Wilson,et al.  Analysis of the effect of changing environmental conditions on the expression patterns of exported surface-associated proteins of the oral pathogen Actinobacillus actinomycetemcomitans. , 2001, Microbial Pathogenesis.

[38]  G. Payonk,et al.  Adjunctive treatment with subantimicrobial doses of doxycycline: effects on gingival fluid collagenase activity and attachment loss in adult periodontitis. , 2001, Journal of clinical periodontology.

[39]  G. Trinchieri,et al.  Inhibition of IL-12 Production in Human Monocyte-Derived Macrophages by TNF1 , 2000, The Journal of Immunology.

[40]  A. V. van Winkelhoff,et al.  Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in nonoral infections. , 1999, Periodontology 2000.

[41]  P. Fives-Taylor,et al.  Virulence factors of Actinobacillus actinomycetemcomitans. , 1999, Periodontology 2000.

[42]  D. Graves,et al.  Interleukin-1 and tumor necrosis factor antagonists inhibit the progression of inflammatory cell infiltration toward alveolar bone in experimental periodontitis. , 1998, Journal of periodontology.

[43]  L. Shapira,et al.  Effects of Tetracyclines on the Pathologic Activity of Endotoxin: in Vitro and in Vivo Studies , 1998, Advances in dental research.

[44]  G. Trinchieri,et al.  Positive and negative regulation of interleukin-12 gene expression. , 1998, European cytokine network.

[45]  T. Salo,et al.  Matrix Metalloproteinase-8 Is Expressed in Rheumatoid Synovial Fibroblasts and Endothelial Cells , 1997, The Journal of Biological Chemistry.

[46]  R. Page,et al.  The host response to the microbial challenge in periodontitis: assembling the players. , 1997, Periodontology 2000.

[47]  R. Arnold,et al.  Monocytic TNF alpha secretion patterns in IDDM patients with periodontal diseases. , 1997, Journal of clinical periodontology.

[48]  L. Shapira,et al.  Protection against endotoxic shock and lipopolysaccharide-induced local inflammation by tetracycline: correlation with inhibition of cytokine secretion , 1996, Infection and immunity.

[49]  A. V. van Winkelhoff,et al.  Systemic antibiotic therapy in periodontics. , 1996, Periodontology 2000.

[50]  J. Bartova,et al.  Local antibodies and cytokine responses in crevicular fluid of patients with juvenile periodontitis. , 1995, Advances in experimental medicine and biology.

[51]  L. Golub,et al.  Doxycycline and Chemically Modified Tetracyclines Inhibit Gelatinase A (MMP‐2) Gene Expression in Human Skin Keratinocytes , 1994, Annals of the New York Academy of Sciences.

[52]  S. Socransky,et al.  Microbial etiological agents of destructive periodontal diseases. , 1994, Periodontology 2000.

[53]  Y. Kono,et al.  Gingival mononuclear cells from chronic inflammatory periodontal tissues produce interleukin (IL)-5 and IL-6 but not IL-2 and IL-4. , 1993, The American journal of pathology.

[54]  Volker Herzog,et al.  Establishment of a human cell line (mono mac 6) with characteristics of mature monocytes , 1988, International journal of cancer.

[55]  M. Listgarten,et al.  Bacteroides gingivalis, Bacteroides intermedius and Actinobacillus actinomycetemcomitans in human periodontal diseases. , 1988, Journal of clinical periodontology.

[56]  S. Socransky,et al.  The effect of treatment on Actinobacillus actinomycetemcomitans in localized juvenile periodontitis. , 1986, Journal of periodontology.